Therapeutic plasma exchange in patients with sepsis: Secondary analysis of a cluster-randomized controlled trial |
03/13/2024 - 3:30pm to 4:30pm EDT |
Stem cell mobilizating effect of heparin in patients undergoing autologous stem cell transplantation |
11/15/2023 - 3:30pm to 4:30pm EST |
Ethylene oxide-type hypersensitivity reactions in G-CSF mobilized, peripheral blood hematopoietic progenitor cell donors |
09/27/2023 - 3:30pm to 4:30pm EDT |
Leukapheresis guidance and best practices for optimal chimeric antigen receptor T-cell manufacturer |
08/16/2023 - 3:30pm to 4:30pm EDT |
Efficacy and cost of double filtration plasmapheresis in severe hypertriglyceridemia-induced pancreatitis: A retrospective observational study |
08/09/2023 - 3:30pm to 4:30pm EDT |
The ADAPT trial for myasthenia gravis |
05/31/2023 - 3:30pm to 4:03pm EDT |
Successful treatment of pure red cell aplasia using therapeutic plasma exchange after ABO-incompatible hematopoietic stem cell transplant |
02/22/2023 - 3:30pm to 4:30pm EST |
Drug dosing in patients undergoing therapeutic plasma exchange |
01/25/2023 - 3:30pm to 4:30pm EST |
Comprehensive guide to managing a chronic automated red cell exchange program in sickle cell disease |
11/09/2022 - 3:30pm to 4:30pm EST |
Safety and Tolerability of Solvent/Detergent-Treated Plasma for Pediatric Patients Requiring Therapeutic Plasma Exchange |
10/19/2022 - 3:30pm to 4:30pm EDT |